International Guideline Harmonization Group
Home
About IGHG
Members
Core group
Guideline panels
Bone mineral density
Breast cancer
Cardiomyopathy
Central nervous system neoplasms
Colorectal cancer
Coronary artery disease
Dexrazoxane cardioprotection
Dyslipidemia
Fatigue, mental health and psychosocial problems
Fertility preservation
Growth hormone treatment
Health promotion
Hepatic toxicity
Hypothalamic-pituitary dysfunction
Male gonadotoxicity
Metabolic syndrome
Nephrotoxicity
Neurocognitive problems
Obstetric care
Osteonecrosis
Ototoxicty
Premature ovarian insufficiency
Pulmonary dysfunction
Splenic dysfunction
Thyroid cancer
Thyroid dysfunction
Anthracycline cardiotoxicity equivalence ratio
COVID-19 Statement
Collaborators
Funding sources
Methods
Process
Grading system
Topic selection
Publication
Handbook
Guidelines
Topics
Bone mineral density
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Breast cancer
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Cardiomyopathy
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Central nervous system neoplasms
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Colorectal cancer
Guideline panel
Coronary artery disease
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Dexrazoxane cardioprotection
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Fatigue
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Fertility preservation
Recommendations
Conclusions of evidence
Evidence tables
Publications
Guideline panel
Growth hormone treatment
Guideline panel
Health promotion
Guideline panel
Hepatic toxicity
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Hypothalamic-pituitary dysfunction
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Male gonadotoxicity
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Mental health problems
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Metabolic syndrome
Guideline panel
Nephrotoxicity
Guideline panel
Neurocognitive problems
Guideline panel
Obstetric care
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Ototoxicity
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Premature ovarian insufficiency
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Psychosocial problems
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Pulmonary dysfunction
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Splenic dysfunction
Guideline panel
Thyroid cancer
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Thyroid dysfunction
Guideline panel
Anthracycline cardiotoxicity equivalence ratio
Guideline panel
COVID-19 Statement
Patient education
News
Meetings
Contact
Guideline panels
Home
International Guideline Harmonization Group
Members
Guideline panels
Thyroid dysfunction
Thyroid dysfunction